A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Inclusion Criteria

• •Aged greater than or equal to (\>=) 18 years at the time of consent or start of chart abstraction in case a consent waiver will be allowed as per local regulation.
• •Received an HSCT/SOT.
• •Diagnosed with CMV infection/disease any time after the HSCT/SOT date.
• •Initiated maribavir at least 4 months before the chart abstraction date (or at time of Central Ethics Committee \[CEC\]/Local Ethics Committee \[LEC\] submission as per local regulation).
• •Participants with hospital medical chart available, who signed an informed consent form before starting any study procedures (unless waiver is allowed as per local regulation).